Increasing expenditure in research activities together with rising competition is primarily driving the vaccine technologies market size over the forecast time span. Moreover, rising competition is promoting the industry players to introduce innovate products in the marketplace, thereby enhancing the industry revenue generation. Other factors such as changing lifestyles will further improve the industry size.
Rising number of diseases and increasing population across the globe is positively affecting the vaccine technologies market size during the study period. Development of immunization programs across the emerging countries will support in increasing industry volume. Emergence of new pandemics will enhance the business growth.
Global vaccine technologies market is segmented based on the human vaccine as, Attenuated (Live) Vaccines, Inactivated Vaccines, Conjugate Vaccines, rDNA/DNA Vaccines, Subunit Vaccines, Toxoid Vaccines, Combination Vaccines, Vaccine by Age Group, Vaccine by Disease Type. On the basis of animal vaccine, the global vaccine technologies market is segregated as Attenuated Vaccines, Inactivated Vaccine, Subunit Vaccine, Toxoid Vaccine, Conjugate Vaccines, Recombinant Vaccine, DNA Vaccine, Vaccine by Animal Type. Combination vaccines is expected to witness notable gains in the forecast years.
Global vaccine technologies market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional vaccine technologies market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Global vaccine technologies market share consists of several players including Astrazeneca, Boehringer Ingelheim, GE Healthcare, Glaxosmithkline, Johnson & Johnson, LG Life Sciences, Novartis, Merck, Serum Institute of India, and Thermo Fisher Scientific.
The Vaccine Technologies Market has been segmented as below:
Vaccine Technologies Market, By Human Vaccine
Vaccine Technologies Market, By Animal Vaccine
Vaccine Technologies Market, By Region
The report covers:
Report scope:
The global vaccine technologies market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Astrazeneca, Boehringer Ingelheim, GE Healthcare, Glaxosmithkline, Johnson & Johnson, LG Life Sciences, Novartis, Merck, Serum Institute Of India, and Thermo Fisher Scientific.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Clinical Immunochemistry Analyzers Market
Companion Animal Vaccines Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Increasing human population
4.2.2. Growing demand for pet insurance
4.2.3. Rising animal health expenditure
4.3. Restraints
4.3.1. Highly competitive
4.4. Opportunities
4.4.1. Advancement in vaccine products
4.4.2. Launch of combination products
4.5. Challenges
4.5.1. Lack of animal health awareness
5. Vaccine Technologies Market, By Human Vaccine
5.1. Key Points
5.2. Attenuated (Live) Vaccines
5.3. Inactivated Vaccines
5.4. Conjugate Vaccines
5.5. rDNA/DNA Vaccines
5.6. Subunit Vaccines
5.7. Toxoid Vaccines
5.8. Combination Vaccines
5.9. Vaccine by Age Group
5.10. Vaccine by Disease Type
6. Vaccine Technologies Market, By Animal Vaccine
6.1. Key Points
6.2. Attenuated Vaccines
6.3. Inactivated Vaccine
6.4. Subunit Vaccine
6.5. Toxoid Vaccine
6.6. Conjugate Vaccines
6.7. Recombinant Vaccine, DNA Vaccine
6.8. Vaccine by Animal Type
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profile
8.1. AstraZeneca
8.1.1. Company Overview
8.1.2. Product/Service Landscape
8.1.3. Financial Overview
8.1.4. Recent Developments
8.2. Boehringer Ingelheim
8.2.1. Company Overview
8.2.2. Product/Service Landscape
8.2.3. Financial Overview
8.2.4. Recent Developments
8.3. GE Healthcare
8.3.1. Company Overview
8.3.2. Product/Service Landscape
8.3.3. Financial Overview
8.3.4. Recent Developments
8.4. GlaxoSmithKline
8.4.1. Company Overview
8.4.2. Product/Service Landscape
8.4.3. Financial Overview
8.4.4. Recent Developments
8.5. Johnson & Johnson
8.5.1. Company Overview
8.5.2. Product/Service Landscape
8.5.3. Financial Overview
8.5.4. Recent Developments
8.6. LG Life Sciences
8.6.1. Company Overview
8.6.2. Product/Service Landscape
8.6.3. Financial Overview
8.6.4. Recent Developments
8.7. Novartis
8.7.1. Company Overview
8.7.2. Product/Service Landscape
8.7.3. Financial Overview
8.7.4. Recent Developments
8.8. Merck
8.8.1. Company Overview
8.8.2. Product/Service Landscape
8.8.3. Financial Overview
8.8.4. Recent Developments
8.9. Serum Institute Of India
8.9.1. Company Overview
8.9.2. Product/Service Landscape
8.9.3. Financial Overview
8.9.4. Recent Developments
8.10. Thermo Fisher Scientific
8.10.1. Company Overview
8.10.2. Product/Service Landscape
8.10.3. Financial Overview
8.10.4. Recent Developments
The Vaccine Technologies Market has been segmented as below:
Vaccine Technologies Market, By Human Vaccine
Vaccine Technologies Market, By Animal Vaccine
Vaccine Technologies Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
